Neogenomics NEO
NASDAQ NEO
$19.11 -0.30 (-1.55%)
As of: Sep 22, 2026 · 10:51 AM EDT

Neogenomics (NEO) Liabilities from Discontinued Operations (2025)

Neogenomics' (NEO) quarterly Liabilities from Discontinued Operations came in at $478000.0 in Q3 2025, up 4.82% quarter-over-quarter from $456000.0 in Q2 2025.

Analysis

Neogenomics (NEO) Liabilities from Discontinued Operations (2025) Analysis & Trends

Neogenomics (NEO) has reported Liabilities from Discontinued Operations for 1 consecutive years, with $478000.0 the latest figure, recorded in Q3 2025.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn
10 Neogenomics 2.55 Bn 2.40 Bn 91.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 478,000.00
Jun 30, 2025 456,000.00
API Access

Neogenomics Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=NEO&period=max&api_key=YOUR_API_KEY